Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Neuropsychopharmacology. 2008 Oct 22;34(5):1277–1287. doi: 10.1038/npp.2008.194

Table 1.

Demographic and clinical characterization of the study samples.

Control (n=19) MDD (n=18)
Proportion Female (n) 58% (11) 61% (11)
Age (mean±SD) 31 ± 8.5 31 ± 11
Proportion Right-Handed (n) 100% (19) 100% (18)
Depression Ratings
  MADRS (mean±SD) 0.47 ± 1.2 22 ± 5.3
  IDS-C (mean±SD) 0.59 ± 1.3 27 ± 6.5
Anxiety Ratings
  HAMA (mean±SD) 0.59 ± 1.2 12 ± 4.3
Anhedonia IDS_C Ratings (Mean ± SD) 0.06 ± 0.2 9.4 ± 3.2
Psychomotor Speed – Response latency on RVIP 437±78 491±118
Age-at-Illness-Onset (yrs) mean±SD (range) N/A 19 ± 10 (6 – 41)
Illness Duration (years) mean±SD (range) N/A 12 ± 8.5 (2 – 32)
Duration Medication-Free, Mos. mean±SD (range) N/A 23 ± 35 (4 – 96)
Treatment Naïve (n) 19 11
Subjects with Remote History of Suicide Attempts (n) 0 4
Prior Exposure to Antipsychotic Agent (n) 0 1
Remote History of Alcohol (2) or Marijuana (1) Abuse (n) 0 3
Comorbid Anxiety Disorder (n) 0 5

Abbreviations. MADRS, Montgomery Asberg Depression Rating Scale; HAM-A, Hamilton Rating Scale for Anxiety; IDS-C, Inventory of Depressive Symptoms-Clinician Rated; RVIP, Rapid Visual Information Processing